Literature DB >> 9256494

Construction of hybrid proteins that migrate retrogradely and transynaptically into the central nervous system.

L Coen1, R Osta, M Maury, P Brûlet.   

Abstract

The nontoxic proteolytic C fragment of tetanus toxin (TTC peptide) has the same ability to bind nerve cells and be retrogradely transported through a synapse as the native toxin. We have investigated its potential use as an in vivo neurotropic carrier. In this work we show that a hybrid protein encoded by the lacZ-TTC gene fusion retains the biological functions of both proteins in vivo-i.e. , retrograde transynaptic transport of the TTC fragment and beta-galactosidase enzymatic activity. After intramuscular injection, enzymatic activity could be detected in motoneurons and connected neurons of the brainstem areas. This strategy could be used to deliver a biological activity to neurons from the periphery to the central nervous system. Such a hybrid protein could also be used to map synaptic connections between neural cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9256494      PMCID: PMC23202          DOI: 10.1073/pnas.94.17.9400

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  39 in total

1.  Transsynaptic retrograde transport of fragment C of tetanus toxin demonstrated by immunohistochemical localization.

Authors:  C Evinger; J T Erichsen
Journal:  Brain Res       Date:  1986-08-20       Impact factor: 3.252

Review 2.  [Gene therapy in neurology. State of the art and future prospects].

Authors:  R G Duarte
Journal:  Neurologia       Date:  1995-12       Impact factor: 3.109

3.  The complete nucleotide sequence of tetanus toxin.

Authors:  N F Fairweather; V A Lyness
Journal:  Nucleic Acids Res       Date:  1986-10-10       Impact factor: 16.971

4.  Use of the B-IIb tetanus toxin derived fragment as a specific neuropharmacological transport agent.

Authors:  B Bizzini; P Grob; M A Glicksman; K Akert
Journal:  Brain Res       Date:  1980-07-07       Impact factor: 3.252

5.  Tetanus toxin: evidence for binding at presynaptic nerve endings.

Authors:  D L Price; J W Griffin; K Peck
Journal:  Brain Res       Date:  1977-02       Impact factor: 3.252

6.  Brain stem afferents of hypoglossal neurons in the rat.

Authors:  R C Borke; M E Nau; R L Ringler
Journal:  Brain Res       Date:  1983-06-13       Impact factor: 3.252

7.  Retrograde transneuronal transfer of the C-fragment of tetanus toxin.

Authors:  P S Fishman; D R Carrigan
Journal:  Brain Res       Date:  1987-03-17       Impact factor: 3.252

8.  Selective trans-synaptic migration of tetanus toxin after retrograde axonal transport in peripheral sympathetic nerves: a comparison with nerve growth factor.

Authors:  M Schwab; H Thoenen
Journal:  Brain Res       Date:  1977-02-25       Impact factor: 3.252

9.  Association of the H-Y male antigen with beta2-microglobulin on human lymphoid and differentiated mouse teratocarcinoma cell lines.

Authors:  M Fellous; E Günther; R Kemler; J Wiels; R Berger; J L Guenet; H Jakob; F Jacob
Journal:  J Exp Med       Date:  1978-07-01       Impact factor: 14.307

10.  Tetanus toxin: primary structure, expression in E. coli, and homology with botulinum toxins.

Authors:  U Eisel; W Jarausch; K Goretzki; A Henschen; J Engels; U Weller; M Hudel; E Habermann; H Niemann
Journal:  EMBO J       Date:  1986-10       Impact factor: 11.598

View more
  23 in total

1.  Neuronal activity-dependent membrane traffic at the neuromuscular junction.

Authors:  Francisco Javier Miana-Mena; Sylvie Roux; Jean-Claude Benichou; Rosario Osta; Philippe Brûlet
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-05       Impact factor: 11.205

Review 2.  Molecular neuroanatomy's "Three Gs": a primer.

Authors:  Susan M Dymecki; Jun Chul Kim
Journal:  Neuron       Date:  2007-04-05       Impact factor: 17.173

Review 3.  How do genes regulate simple behaviours? Understanding how different neurons in the vertebrate spinal cord are genetically specified.

Authors:  Katharine E Lewis
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-01-29       Impact factor: 6.237

4.  A conformational change of C fragment of tetanus neurotoxin reduces its ganglioside-binding activity but does not destroy its immunogenicity.

Authors:  Rui Yu; Shaoqiong Yi; Changming Yu; Ting Fang; Shuling Liu; Ting Yu; Xiaohong Song; Ling Fu; Lihua Hou; Wei Chen
Journal:  Clin Vaccine Immunol       Date:  2011-08-03

5.  Motor neuron targeting of IGF-1 attenuates age-related external Ca2+-dependent skeletal muscle contraction in senescent mice.

Authors:  Anthony M Payne; María Laura Messi; Zhenlin Zheng; Osvaldo Delbono
Journal:  Exp Gerontol       Date:  2006-12-14       Impact factor: 4.032

6.  Motor neurone targeting of IGF-1 prevents specific force decline in ageing mouse muscle.

Authors:  Anthony M Payne; Zhenlin Zheng; María Laura Messi; Carol E Milligan; Estela González; Osvaldo Delbono
Journal:  J Physiol       Date:  2005-11-17       Impact factor: 5.182

Review 7.  Gene transfer in the nervous system and implications for transsynaptic neuronal tracing.

Authors:  Youngbuhm Huh; Myung S Oh; Pierre Leblanc; Kwang-Soo Kim
Journal:  Expert Opin Biol Ther       Date:  2010-05       Impact factor: 4.388

8.  Effects of gene therapy on muscle 18S rRNA expression in mouse model of ALS.

Authors:  María Moreno-Igoa; Raquel Manzano; Sara Oliván; Ana C Calvo; Janne M Toivonen; Rosario Osta
Journal:  BMC Res Notes       Date:  2010-11-02

9.  Fragment C of tetanus toxin, more than a carrier. Novel perspectives in non-viral ALS gene therapy.

Authors:  María Moreno-Igoa; Ana Cristina Calvo; Clara Penas; Raquel Manzano; Sara Oliván; María Jesús Muñoz; Renzo Mancuso; Pilar Zaragoza; José Aguilera; Xavier Navarro; Rosario Osta Pinzolas
Journal:  J Mol Med (Berl)       Date:  2010-03       Impact factor: 4.599

10.  Pax6 and engrailed 1 regulate two distinct aspects of renshaw cell development.

Authors:  Tamar Sapir; Eric J Geiman; Zhi Wang; Tomoko Velasquez; Sachiko Mitsui; Yoshihiro Yoshihara; Eric Frank; Francisco J Alvarez; Martyn Goulding
Journal:  J Neurosci       Date:  2004-02-04       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.